Cancer Therapeutics is a highly successful cancer research organisation with expertise in small molecule drug discovery and oncology trial design. With the ultimate goal of finding cures for cancer, Cancer Therapeutics brings together the best researchers from the best organisations to create dynamic partnerships that make innovative discoveries.
Cancer Therapeutics is in the process of making the much-anticipated move from a Cooperative Research Centre (CRC) to a private company – a transition that only a handful of CRCs have successfully completed.
Cancer Therapeutics CRC was founded in 2007 using government Cooperative Research Centre Program (CRC) funding and since then has commercialised multiple drug discovery projects, has partnered with world leading pharmaceutical giants and secured two of the largest preclinical deals in Australia. To date, Cancer Therapeutics CRC has secured over $40 million in licensing revenue and created numerous employment opportunities within the Australian biotechnology industry.
Cancer Therapeutics CRC provided the seed funding for a personalised treatment program for paediatric patients at Children’s Cancer Institute, called Zero Childhood Cancer. After a successful pilot program in 2016, the study has been expanded Australia-wide and is already delivering personalised treatment options to paediatric patients.
We have also convened a global working group with the FDA in the US to influence the regulation around drugs for treatment of early metastasis and the results from this working group have been published in a Consensus Statement in the journal, Nature Reviews Clinical Oncology.